Trials / Completed
CompletedNCT00136266
Adherence With Iron Sprinkles Among High-Risk Infants
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 128 (actual)
- Sponsor
- Centers for Disease Control and Prevention · Federal
- Sex
- All
- Age
- 5 Months – 7 Months
- Healthy volunteers
- Accepted
Summary
Compared with iron drops, iron sprinkles supplied for 3 months to high-risk children beginning at age 5-7 months will increase adherence and reduce the rates of anemia and iron deficiency.
Detailed description
Iron deficiency is the most common known nutrient deficiency and cause of anemia in childhood. It is associated with numerous adverse health effects, particularly delayed mental and motor development, that may be irreversible. Despite advances of iron nutrition, the prevalence of iron deficiency remains high among low-income infants and toddlers. Previous studies suggest adherence with iron containing drops is low. Adherence to iron sprinkles among children as tested in studies in less developed countries appears high. Comparison: Children randomized to ferrous sulfate drops will be compared with children randomized to ferrous fumarate sprinkles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferrous sulphate drops with vitamins A, D, and C | |
| DRUG | Ferrous fumarate sprinkles with vitamins and minerals |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2005-12-01
- Completion
- 2005-12-01
- First posted
- 2005-08-29
- Last updated
- 2016-02-03
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00136266. Inclusion in this directory is not an endorsement.